Explore how a scientific erratum in HIV research reveals the self-correcting nature of science and advances our understanding of vaccine development.
Exploring the prevalence of renal impairment in virologically suppressed people living with HIV based on findings from the COCOMO study.
Discover the groundbreaking chimeric protein-based HIV-1 fusion inhibitor TLT35 that targets gp41 with exceptional potency and stability against drug-resistant strains.
How antiretroviral therapy has revolutionized pregnancy outcomes for HIV-positive women, reducing transmission rates to less than 1%.
Exploring the BASE study results on B/F/TAF efficacy in HIV patients with substance use disorders and the intersection of medical treatment with social challenges.
Research on viral load suppression timelines and associated factors for HIV patients in Ethiopia's East Shewa zone.
Exploring the syndemic of HIV, comorbidities and functional decline in Brazil's Amazon region, with focus on Belém, Pará.
Exploring the discrepancy between self-reported medication adherence and virologic outcomes in HIV patients in Nigeria.
Discover how transient viremia in SIV-infected macaques leads to stronger immune responses and what this means for HIV vaccine design.
South Africa's HIV landscape is a study in contrasts: home to the world's largest HIV-positive population yet a pioneer in cutting-edge research and public health initiatives.